We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Cryo-Cell International Inc (CCEL) USD0.01

Sell:$12.55 Buy:$12.64 Change: $0.0007 (0.01%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.0007 (0.01%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.0007 (0.01%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Cryo-Cell International, Inc. (Cryo-Cell) cord blood banking company. The Company/Cryo-Cell operates its own processing, testing and cryopreservation operation. The Company operates through three segments: cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use; manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens worldwide for the benefit of new-born babies and other members of their families.

Contact details

700 Brooker Creek Blvd Ste 1800
United States
+1 (813) 7492104

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$109.39 million
Shares in issue:
8.53 million
Health Care Services
United States
US dollar

Key personnel

  • David Portnoy
    Chairman of the Board, Co-Chief Executive Officer
  • Mark Portnoy
    Co-Chief Executive Officer, Director
  • Jill Taymans
    Chief Financial Officer, Vice President - Finance
  • Oleg Mikulinsky
    Chief Information Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.